A Novel Murine Model of Marfan Syndrome Accelerates Aortopathy and Cardiomyopathy
Authors:
- 24 March 2017
- journal article
- research article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 104 (2) , 657-665
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Depletion of Endothelial or Smooth Muscle Cell-Specific Angiotensin II Type 1a Receptors Does Not Influence Aortic Aneurysms or Atherosclerosis in LDL Receptor Deficient MicePLOS ONE, 2012
- Development of a novel murine model of aortic aneurysms using peri-adventitial elastaseSurgery, 2012
- Lessons on the pathogenesis of aneurysm from heritable conditionsNature, 2011
- Angiotensin II Type 2 Receptor Signaling Attenuates Aortic Aneurysm in Mice Through ERK AntagonismScience, 2011
- Noncanonical TGFβ Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome MiceScience, 2011
- Endothelial Cell–Specific Deficiency of Ang II Type 1a Receptors Attenuates Ang II–Induced Ascending Aortic Aneurysms in LDL Receptor −/− MiceCirculation Research, 2011
- Marfan syndrome: 30 years of research equals 30 years of additional life expectancyHeart, 2008
- Imbalanced synthesis of cyclooxygenase‐derived thromboxane A2 and prostacyclin compromises vasomotor function of the thoracic aorta in Marfan syndromeBritish Journal of Pharmacology, 2007
- Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan SyndromeScience, 2006
- Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells.Proceedings of the National Academy of Sciences, 1992